Myasthenia gravis and autoimmune overlap: Prognostic insight
Comorbid ADs do not significantly impact MG severity or prognosis. Female MG patients with ADs have a higher frequency of myasthenic exacerbations and rituximab use, warranting further research. Early identification of ADs remains essential for optimal patient management.
Authors
- Emel Oguz‐Akarsu (ORCID: https://orcid.org/0000-0002-0465-4218)
- Gizem Güllü (ORCID: https://orcid.org/0000-0001-9477-5031)
- Furkan Sarıdaş (ORCID: https://orcid.org/0000-0001-5945-2317)
- Deniz Sığırlı (ORCID: https://orcid.org/0000-0002-4006-3263)
- Yasemin Dinç (ORCID: https://orcid.org/0000-0003-0342-5939)
- Necdet Karlı (ORCID: https://orcid.org/0000-0002-7734-6451)
- Sarra El hamida Lazrak
Institutions
- Bursa Uludağ Üni̇versi̇tesi̇ (TR)
- United Arab Emirates University (AE)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1371/journal.pone.0334434
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00